Guardant tests for cancer screening, recurrence monitoring and treatment selection will be available to patients through Bayshore HealthCare providers PALO ALTO, Calif. — Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced it has entered into an agreement with Bayshore HealthCare, a leading home and community healthcare service provider in Canada, to […]